Restrictive versus goal-directed fluid replacement strategy in ovarian cancer cytoreductive surgery (RiGoROCS): A randomised controlled trial.
Jyotsna GoswamiAngshuman Rudra PalSuparna Mitra BarmanAnshuman SarkarViplab PatroJaydip BhowmikAsima MukhopadhyayPublished in: Indian journal of anaesthesia (2023)
GDFT did not confer significant benefit over restrictive fluid therapy in ovarian cancer CRS regarding hospital LOS.